Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Dividends payables (2016)

Altimmune (ALT) has disclosed Dividends payables for 1 consecutive years, with $197.1 million as the latest value for Q4 2016.

  • On a quarterly basis, Dividends payables changed N/A to $197.1 million in Q4 2016 year-over-year; TTM through Dec 2016 was $197.1 million, a N/A change, with the full-year FY2016 number at $197.1 million, changed N/A from a year prior.
  • Dividends payables was $197.1 million for Q4 2016 at Altimmune.
  • In the past five years, Dividends payables ranged from a high of $197.1 million in Q4 2016 to a low of $197.1 million in Q4 2016.